Panelist: Sigmund Silber, Ran Kornowski, Hany Ragy, Patrick Serruys ENGLISH-RUSSIAN SIMULTANEOUS TRANSLATED SESSION

Size: px
Start display at page:

Download "Panelist: Sigmund Silber, Ran Kornowski, Hany Ragy, Patrick Serruys ENGLISH-RUSSIAN SIMULTANEOUS TRANSLATED SESSION"

Transcription

1 Monday, December 05, :00-08:30 REGISTRATION, EXHIBITION VISIT AND COFFEE Exhibition Hall 08:30-10:00 PARALLEL SESSIONS S1-S6 08:30-10:00 S1 - Biodegradable Scaffolds: A Shifting Paradigm in Vascular Restoration Chairs: Ran Kornowski, Israel Hany Ragy, Egypt Patrick Serruys, The Netherlands 08:30 Introduction and Defining of the Unmet Needs Ran Kornowski Rabin Medical Center, Campus Beilinson, Israel 08:42 Building the Case for Bioresorbable Scaffolds: Abbott Vascular's ABSORB Program Update Richard Rapoza Abbott Vascular, USA 08:54 Update on the Biotroniks' Magnesium Alloy Program and BIOSOLVE-I Ron Waksman Division of Cardiology, Washington Hospital, USA 09:06 Novel PLA-dedicated Scaffold for Vascular Reconstruction Antoine LaFont Hopital European Georges Pompidou, France 09:18 Bioresorbable stents 5 Years Follow-up of ABSORB Cohort A Dariusz Dudek University Hospital in Krakow, Poland 09:30 Fully Bioabsorbable Stents: The Future is Here Refat Jabara Hadassah Hebrew University Medical Center 09:42 Panel Discussion and Needs for the Future Panelist: Sigmund Silber, Ran Kornowski, Hany Ragy, Patrick Serruys 08:30-10:00 S2 - Aortic Valve Interventions I Chairs: Martin Leon, USA Chaim Lotan, Israel Gerhard Schuler, Germany Hall B ENGLISH-RUSSIAN SIMULTANEOUS TRANSLATED SESSION 08:30 TAVI- Past, Present and Future: What are the Remaining Unmet Needs? Cribier Alain Hospital Charles Nicolle, University of Rouen, France 08:42 The Milan Combined Experience with Safierand Core Valve Antonio Colombo EMO GVM Centro Cuore Columbus, Italy Innovations in Cardiovascular Interventions (ICI 2011) 46

2 Monday, December 05, :30-14:00 LUNCH BREAK 12:45-13:45 LUNCH SESSION 1 - Thrombus Management in STEMI with MGuard Micro-Mesh Technology: Complex Lesions and the MASTER Trial Chairs: Chaim Lotan, Israel Gregg W. Stone, USA Exhibition Hall Hall H Sponsored by InspireMD Panel: Yaron Almagor, Antonio Colombo, Dariusz Dudek, Hugo Londero, Sigmund Silber 12:45 Unmet Needs, MGuard and the MASTER Trial Gregg W. Stone 12:55 MGuard in Acute MI: Long term Follow-up Dariusz Dudek MGuard for Complex Lesions 13:05 Antonio Colombo Challenging MGuard Cases 13:15 Abid Assali, S. Hiremath, Hugo Londero 13:35 Panel Discussion & Take Home Messages Gregg W. Stone 13:45 Adjourn 12:45-13:45 LUNCH SESSION 2 - Mastering the Art of TAVI Cuisine - Recipes from the Master Chefs Chairs: Victor Guetta, Israel Martin Leon, USA Hall I Sponsored by Edwards Lifesciences Today's Focus: Cooking Techniques Selecting the Appropriate Vintage and Menu Chef Alec Vahanian Which Recipe for which Dish? Chef Chris Young Seasoning is Critical-la Nouvelle Cuisine Chef Alain Cribier Innovations in Cardiovascular Interventions (ICI 2011) 51

3 Monday, December 05, :10-17:40 S15 - Cell Therapy (Cont.) 16:34 New Strategies for Infarct Repair Jonathan Leor Sheba Medical Center, Tel Hashomer, Israel Hall C 16:46 Cardiovascular Applications of Pluripotent Stem Cells Lior Gepstein Technion, Israel, Rambam Medical Center, OIsrael 16:58 Placental Derived Cells for the Treatment of Peripheral Vascular Disease - FDA/EMA Approved Phase I/IIa Clinical Study Results Zami Aberman Stanford University School of Medicine, USA 17:10 Endovascular Stem Cell Therapy for End Stage Liver Disease: Results from FIM Nickolas Kipshidze N. Kipshidze Central University Hospital, Tbilisi, Georgia 17:22 Panel Discussion and Needs for the Future 16:10-17:40 S16 - DES and Stents of the Future Chairs: Darius Dudek, Poland Lijun Jin, China Ricardo Krakover, Israel Hall H 16:10 From Avantgarde to Cre8 Polymer-Free DES Antonio Colombo EMO GVM Centro Cuore Columbus, Italy 16:22 The RESOLUTE Global Clinical Program with Focus on Patients with Diabetes Mellitus Sigmund Silber Heart Center at the Isar, Germany 16:34 Stent Bifurcation: Results of Bifurcation Lesions PCI using Resolute DES: Pooled Analysis Data Ran Kornowski Rabin Medical Center, Campus Beilinson, Israel 16:46 Pericardium Covered Stents: Current and Potential Applications Carlo Di Mario Royal Brompton Hospital, London, UK 16:58 Novel Stent Platform with a Hybrid Coating: Clinical Outlook of the Orsiro Hybrid DES with Bioabsorbable Polymer and a Passive Coating Thomas Pilgrim Bern University Hospital, Switzerland Innovations in Cardiovascular Interventions (ICI 2011) 59

4 Tuesday, December 06, :45-13:45 LUNCH SESSION 4 - MitraClip: Multidisciplinary Approach to Treat Mitral Regurgitation Chairs: Gad Keren, Israel Alec Vahanian, France Hall I Sponsored by Abbott Vascular-Levant Introduction Cardiac Surgeon Perspective: Patient Selection and the European Mitraclip Experience Franceso Maisano EchoCardiologist Perspective: TEE (2D and 3D) - A New Vision for Interventional Procedures Adi Butnaru Interventional Cardiologist Perspective: Case based Discussion Alec Vahanian Best Practices for a Successful Referral Program: Discussion 12:45-13:45 LUNCH SESSION 5 - Pericardium Covered Stent: A Reality Chair: Haim Danenberg, Israel Hall J Sponsored by ITGI 12:45 Introduction 12:50 The Reality in Neuro-Interventions Hannes Meyn 13:10 The Reality in Coronary Interventions Alaide Chieffo 13:25 The No Reflow Fear Factor Graham Cassel 13:35 My Worst Case Shmuel Banai 14:00-15:40 PARALLEL SESSIONS S31-S36 14:00-15:40 S31 - New DES and Beyond Chais: Yoseph Rozenman, Israel Sigmund Silber, Germany 14:00 Introduction: Current state of DES and Unmet Needs Yoseph Rozenman The Edith Wolfson Medical Center, Israel 14:12 Long Term DES Safety: Is Polymer Really the Enemy? Mitchell W Krucoff Duke University Medical Center, USA Innovations in Cardiovascular Interventions (ICI 2011) 72

5 Tuesday, December 06, :00-15:40 S31 - New DES and Beyond (Cont.) 14:24 Are Non-Polymeric DES Ready to be Used in Clinical Practice? Jose Ribamar Costa Instituto Dante Pazzanese de Cardiologia, Brazil 14:36 Newer Generation Stents: What and When Louis A Cannon Northern Michigan Regional Hospital, USA, Northern Michigan Regional Hospital, USA, Northern Michigan Regional Hospital, USA 14:48 Evolution of Mitsu Merilimus Eluting Coronary Stent System Sigmund Silber Heart Center at the Isar, Germany 15:00 Stent Conformability & Profile (BMS & DES) Vassilis Voudris Greece 15:12 Axxess and Biomatrix: Simplified Solutions for Treatment of Coronary Bifurcations Mark Steckel Biosensors Europe SA, Switzerland 15:24 Panel Discussion and Needs for the Future 14:00-15:40 S32 - Complex Coronary Lesions Chairs: George Dangas, USA Alexander Goldberg, Israel Bradley Strauss, Canada Hall B ENGLISH-RUSSIAN SIMULTANEOUS TRANSLATED HALL 14:00 The Remaining Unmet Needs in Coronary Interventions Amit Segev Chaim Sheba Medical Center, Israel 14:12 Is it Feasible to Exclude Coronary Aneurysms with bare Metal Stents? Ioannis Iakovou Onassis Cardiac Surgery Center, Greece 14:24 Use of Extraction Devices in Acute Myocardial Infarction- Are we There or Do We Need More Trials? Keyur Parikh Care Institute of Medical Sciences, India 14:36 The Approach to the Non-Revascularized Patients Amir Lerman Mayo Clinic, USA Innovations in Cardiovascular Interventions (ICI 2011) 73

6 Tuesday, December 06, :00-15:40 S36 - Electrophysiology Today and Tomorrow: Clinical Aspects and Unmet Needs (Cont.) Hall J 14:48 Anticoagulation Therapy in AF S Problem Looking for Solutions Eli Lev Rabin Medical Center Hasharon Hospital, Israel 15:00 Limitations of Current CRT Devices Can We Overcome? Jeffrey Martin Banker Hadassah Hebrew University Medical Center, Israel 15:12 Neuromodulation of CHF and Arrhythmias Randy Lieberman Harper University Hospital, USA 15:24 New Innovation addressing Unmet Needs Uri Yaron Biosense Webster (Israel) Ltd, Israel 15:40-16:15 COFFEE BREAK AND EXHIBITION VISIT Exhibition Hall 16:15-18:05 PARALLEL SESSIONS S37-S42 16:15-18:05 S37 - Drug Eluting Balloon Chairs: Abid Assali, Israel Juan Granada, USA Jamal Jafari, Israel 16:15 Drug-Eluting Balloons will have an Important Role in Coronary and Peripheral Interventional Therapy Juan Granada Skirball Center for Cardiovascular Research, The Cardiovascular Research Foundation, USA 16:27 Drug-Eluting Balloons for In-Stent Restenosis after BMS or DES: State-of-the-art Sigmund Silber Heart Center at the Isar, Germany 16:39 Drug Eluting Balloons Ron Waksman Division of Cardiology, Washington Hospital, USA 16:51 The Unmeet Clinical Needs of Coronary Bifurcation: Experimental Data by New Conic DEB Alessandro Santo Bortone University of Bari, Italy Innovations in Cardiovascular Interventions (ICI 2011) 77

Biodegradable Polymer coated Drug Eluting Stents Versus Durable Polymer coated Drug Eluting Stents for Percutaneous Coronary Intervention

Biodegradable Polymer coated Drug Eluting Stents Versus Durable Polymer coated Drug Eluting Stents for Percutaneous Coronary Intervention Biodegradable Polymer coated Drug Eluting Stents Versus Durable Polymer coated Drug Eluting Stents for Percutaneous Coronary Intervention Amos Levi, MD, Tamir Bental, MD, Abid R Assali, MD, Hanna Vaknin-Assa,

More information

The Use of Drug Eluting Stents in Regular Clinical Practice did not Reduce the Clinical Restenosis Rate Compared to Bare Metal Stents.

The Use of Drug Eluting Stents in Regular Clinical Practice did not Reduce the Clinical Restenosis Rate Compared to Bare Metal Stents. The Use of Drug Eluting Stents in Regular Clinical Practice did not Reduce the Clinical Restenosis Rate Compared to Bare Metal Stents. Diab Ghanim, Farid Naoom, Aviva Peleg, Yonathan Hasin Cardiovascular,

More information

Biosensors Technology at Euro PCR 2016

Biosensors Technology at Euro PCR 2016 Biosensors Technology at Euro PCR 2016 Location and timing are subject to change based on the EuroPCR 2016 program Tuesday 17 May Hot Line 11:20-11:28 Main Arena BioFreedom / LEADERS FREE Late-breaking

More information

Catheter-Based Valve-Implantations Using CoreValve and Edwards-Sapien Devices Kornowski, Ran

Catheter-Based Valve-Implantations Using CoreValve and Edwards-Sapien Devices Kornowski, Ran S2 Catheter-Based Valve-Implantations Using CoreValve and Edwards-Sapien Devices Kornowski, Ran 1 ; Dvir, Danny 1 ; Assali, Abid 1 ; Porat, Eyal 2 ; Shapira, Yaron 1 ; Vaknin-Assa, Hana 1 ; Koren, Arnon

More information

Evolution In Interventional Cardiology. Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands

Evolution In Interventional Cardiology. Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands Evolution In Interventional Cardiology Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands 25 November 2010 Coronary Atherosclerosis Timeline in interventional cardiology Indications for

More information

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries

ANGIOPLASY SUMMIT 2007 TCT ASIA PACIFIC. Seoul, Korea: April The problem is exaggerated: Data from Real World Registries ANGIOPLASY SUMMIT 007 TCT ASIA PACIFIC Seoul, Korea: 5-7 7 April 007 15 min Plenary Session: State-of of-the-art Lectures The problem is exaggerated: Data from Real World Registries Antonio Colombo Centro

More information

Sirolimus - Versus Paclitaxel-Eluting Stents: Long-Term Clinical Results in Acute Myocardial Infarction

Sirolimus - Versus Paclitaxel-Eluting Stents: Long-Term Clinical Results in Acute Myocardial Infarction Sirolimus - Versus Paclitaxel-Eluting Stents: Long-Term Clinical Results in Acute Myocardial Infarction Danny Dvir, Abid Assali, Igal Teplisky, Hana Vaknin-Assa, Eli I Lev, Eldad Rechavia, David Brosh,

More information

S20 - Outcome of Coronary Interventions in Complex Lesions and Patients

S20 - Outcome of Coronary Interventions in Complex Lesions and Patients S20 - Outcome of Coronary Interventions in Complex Lesions and Patients A Comparative Analysis of Mortality/Myocardial Infarction Outcomes Using Drug-Eluting Stents vs. Bare Metal Stents in a Large Single

More information

Tailored bifurcation therapy

Tailored bifurcation therapy Tailored bifurcation therapy Dedicated self-expanding platform that conforms to the specific bifurcation anatomy Full bifurcation lesion coverage without creating a false carina Bifurcation DES technology

More information

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Prof. Ran Kornowski, MD, FESC, FACC Director - Division of Interventional Cardiology Rabin Medical Center and Tel Aviv University,

More information

Thursday, December 7 th, 2017, 13:00 14:30

Thursday, December 7 th, 2017, 13:00 14:30 Thursday, December 7 th, 2017, 13:00 14:30 NFIC Opening Ceremony & Session Venue: International Conferencing and Entertainment (ICE) 17 Marii Konopnickiej Street, Krakow, Poland RED ROOM GROUND FLOOR 13:00-13:15

More information

BIOFLOW-III an all comers registry with a Sirolimus Eluting Stent: Presentation of 1-Year TLF Data in patients with complex lesions

BIOFLOW-III an all comers registry with a Sirolimus Eluting Stent: Presentation of 1-Year TLF Data in patients with complex lesions BIOFLOW-III an all comers registry with a Sirolimus Eluting Stent: Presentation of 1-Year TLF Data in patients with complex lesions Johannes Waltenberger, MD, F.E.S.C. Uniklinik Münster Münster, Germany

More information

Bioabsorbable Scaffolding: Technology and Clinical Update. PD Dr. Nicolas Diehm, MD, FESC Inselspital, University Hospital Bern, Switzerland

Bioabsorbable Scaffolding: Technology and Clinical Update. PD Dr. Nicolas Diehm, MD, FESC Inselspital, University Hospital Bern, Switzerland Bioabsorbable Scaffolding: Technology and Clinical Update PD Dr. Nicolas Diehm, MD, FESC Inselspital, University Hospital Bern, Switzerland Disclosures I am not Ron Waksman 1 Clinical experience with AMS

More information

P1 - Posters - Interventional Cardiology

P1 - Posters - Interventional Cardiology Initial TIMI 0-1 Flow is Associated with Worse 30-day Outcomes of Patients Undergoing Primary Percutaneuos Coronary Intervention for Acute Myocardial Infarction David Brosh, Abid Assali, Igal Teplitsky,

More information

The tailored solution for your bifurcation therapy

The tailored solution for your bifurcation therapy The tailored solution for your bifurcation therapy The tailored solution for your bifurcation therapy Dedicated self-expanding platform that conforms to the specific bifurcation anatomy Full bifurcation

More information

TNT Session. The latest clinical evidence in diabetics for the Amphilimus TM eluting polymer-free DES. Rafael Romaguera, MD

TNT Session. The latest clinical evidence in diabetics for the Amphilimus TM eluting polymer-free DES. Rafael Romaguera, MD TNT Session The latest clinical evidence in diabetics for the Amphilimus TM eluting polymer-free DES Rafael Romaguera, MD Hospital de Bellvitge Barcelona Spain Disclosure Statement of Financial Interest

More information

PCI with Polymer-free Stent

PCI with Polymer-free Stent PCI with Polymer-free Stent Florian Krackhardt, M.D. Department of Cardiology Charité Campus Virchow-Klinikum University Hospital Berlin, Germany Drug Eluting Stents: Present Coating Technology Solution

More information

Together. INFINITE POSSIBILITIES.

Together. INFINITE POSSIBILITIES. ST. JUDE MEDICAL IS NOW ABBOTT Together. INFINITE POSSIBILITIES. Abbott and St. Jude Medical have joined together. Visit us at EuroPCR 2017. Join us at our exciting scientific sessions, and explore our

More information

Biosensors Lunch Symposium

Biosensors Lunch Symposium Are Current DES the Final Answer? BioFreedom TM : the Polymer-Free Biolimus A9TM Coated Stent Biosensors Lunch Symposium 25 th April 2013 Prof. Stephen WL Lee, JP 李偉聯 MD FRCP(Lon. Edin. Glas.) FHKCP FHKAM

More information

Coronary Stents: Past, Present and Future

Coronary Stents: Past, Present and Future Kardiologie Kardio Lunch 07.04.2016 Coronary Stents: Past, Present and Future Christoph Kaiser Universitätsspital Basel Rubin GS, The first balloon-expandable coronary stent, University of Queensland Press

More information

OrbusNeich at TCT Late Breaking, Presentations and Poster Sessions

OrbusNeich at TCT Late Breaking, Presentations and Poster Sessions OrbusNeich at TCT Late Breaking, Presentations and Poster Sessions Booth No: 3011 MONDAY, OCTOBER 30 Special Session: 15th Anniversary HBD (Harmonization By Doing): New Synergies in Japan-U.S. Research

More information

Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis Alaide Chieffo

Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis Alaide Chieffo Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis 11.45-12.07 Alaide Chieffo San Raffaele Scientific Institute, Milan, Italy Historical Perspective 25 20 15 10 5 0 Serruys 1991

More information

THE ULTIMATE EVOLUTION IN DES TECHNOLOGY FOR DIABETICS: CRE8 EVO

THE ULTIMATE EVOLUTION IN DES TECHNOLOGY FOR DIABETICS: CRE8 EVO The ultimate EVOlution in DES technology for diabetics: Cre8 EVO THE ULTIMATE EVOLUTION IN DES TECHNOLOGY FOR DIABETICS: CRE8 EVO Rafael Romaguera, MD Barcelona Spain Rafael Romaguera, MD Hospital de Bellvitge

More information

POSTGRADUATE COURSE IN HEART FAILURE A NOVEL COURSE IN HEART FAILURE MANAGEMENT

POSTGRADUATE COURSE IN HEART FAILURE A NOVEL COURSE IN HEART FAILURE MANAGEMENT PCHF POSTGRADUATE COURSE IN HEART FAILURE 3 rd Edition A NOVEL COURSE IN HEART FAILURE MANAGEMENT January 2018 to October 2019 University Hospital Zurich, Switzerland Brussels, Belgium Endorsed by the

More information

Count Down to COMBAT

Count Down to COMBAT Count Down to COMBAT Randomized COMparison of Bypass Surgery versus AngioplasTy using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease Roxana Mehran, MD Associate Professor of

More information

Reduction in Stent Thrombosis better tablets or better stents?

Reduction in Stent Thrombosis better tablets or better stents? Reduction in Stent Thrombosis better tablets or better stents? Dr James Cotton MD FRCP Heart and Lung Centre Wolverhampton MY CONFLICTS OF INTEREST ARE Speaker Fees/Honoraria/Travel Support Lilly/Daiichi

More information

Bioresorbable polymer drug-eluting stents in PCI

Bioresorbable polymer drug-eluting stents in PCI EARN 3 FREE CPD POINTS CARDIOVASCULAR Leader in digital CPD for Southern African healthcare professionals The BIOFLOW-V trial, using the Orsiro ultrathin strut stent with biodegradable polymer, showed

More information

Drug Filled Stent Optical Coherence Tomography Results from RevElution Trial Stent Strut Coverage and Stent Apposition

Drug Filled Stent Optical Coherence Tomography Results from RevElution Trial Stent Strut Coverage and Stent Apposition Drug Filled Stent Optical Coherence Tomography Results from RevElution Trial Stent Strut Coverage and Stent Apposition Prof Martin Rothman on behalf of Dr. Stephen G. Worthley Alexandre Abizaid, Ajay J

More information

FOR IMMEDIATE RELEASE

FOR IMMEDIATE RELEASE FOR IMMEDIATE RELEASE Global Media Contacts: David Schull or Ian Stone Russo Partners +1 212-845-4271 +1 619-528-2220 david.schull@russopartnersllc.com ian.stone@russopartnersllc.com David Kujawa OrbusNeich

More information

From a DES to a BMS* Biosensors Clinical Trial Program. Taking the LEAD in DES Clinical Excellence. From Single de Novo.

From a DES to a BMS* Biosensors Clinical Trial Program. Taking the LEAD in DES Clinical Excellence. From Single de Novo. Biosensors Clinical Trial Program Taking the LEAD in DES Clinical Excellence Our trials gather clinical data for this technology from a wide range of patients, including those with single de novo lesions,

More information

Dr. Robert J. van Geuns. Thoraxcenter ErasmusMC Rotterdam On behalf of Dr. Jean Fajadet and Co-investigators

Dr. Robert J. van Geuns. Thoraxcenter ErasmusMC Rotterdam On behalf of Dr. Jean Fajadet and Co-investigators Complex coronary bifurcation lesions treated with the novel polymer-free dedicated bifurcation paclitaxel-eluting stent (Nile pax): clinical and angiographic results of the prospective, multicenter bipax

More information

Preliminary Programme

Preliminary Programme Preliminary Programme The scientific programme comprises various styles of presentations and sessions, each offering a unique opportunity to amass new and important scientific information. Optimal management

More information

BALLROOM C BALLROOM B SENTRAL BALLROOM Emcee : Chairpersons: Panelists: Updates on MySTEMI Network towards an Ideal STEMI network

BALLROOM C BALLROOM B SENTRAL BALLROOM Emcee : Chairpersons: Panelists: Updates on MySTEMI Network towards an Ideal STEMI network MY LIVE 2016 DAY 1: THURSDAY 28 th July 2016 BALLROOM C BALLROOM B SENTRAL BALLROOM Emcee : 0830-0900 0900-0930 0930-1000 MyLive 15: 1 year outcomes of cases Welcome Address, Opening Ceremony and Sponsors

More information

DARIUSZ DUDEK. Country : POLAND. Application for the following position in the EAPCI Board: PRESIDENT-ELECT. Current position

DARIUSZ DUDEK. Country : POLAND. Application for the following position in the EAPCI Board: PRESIDENT-ELECT. Current position DARIUSZ DUDEK Country : POLAND Application for the following position in the EAPCI Board: PRESIDENT-ELECT Current position Chair of the Education and Training Committee of EAPCI Valve for Life Project

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA152 drug-eluting stents for the treatment of coronary artery disease (part review of TA71) this guidance was originally

More information

PCHF. A novel course in heart failure management POSTGRADUATE COURSE IN HEART FAILURE

PCHF. A novel course in heart failure management POSTGRADUATE COURSE IN HEART FAILURE PCHF POSTGRADUATE COURSE IN HEART FAILURE A novel course in heart failure management Certified by the European Society of Cardiology (ESC) and the University of Zurich. Based on the new curriculum of the

More information

Bioabsorbable stents: early clinical results. Dr Angela Hoye MB ChB, PhD Senior Lecturer in Cardiology Hull & East Yorkshire Hospitals

Bioabsorbable stents: early clinical results. Dr Angela Hoye MB ChB, PhD Senior Lecturer in Cardiology Hull & East Yorkshire Hospitals Bioabsorbable stents: early clinical results Dr Angela Hoye MB ChB, PhD Senior Lecturer in Cardiology Hull & East Yorkshire Hospitals MY CONFLICTS OF INTEREST ARE: Clinical Events Committee member for

More information

Update interventional Cardiology Hans Rickli St.Gallen

Update interventional Cardiology Hans Rickli St.Gallen Update interventional Cardiology 2012 Hans Rickli St.Gallen 26.11.2012 Review of Literature ESC-Highlights TCT/AHA-Highlights Update interventional cardiology 2012 Structural Heart Disease Transcatheter

More information

HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February Drug-eluting stents Are they all equal?

HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February Drug-eluting stents Are they all equal? HCS Working Group Seminars Macedonia Pallas Hotel, Friday 21 st February 2014 Drug-eluting stents Are they all equal? Vassilis Spanos Interventional Cardiologist, As. Director 3 rd Cardiology Clinic Euroclinic

More information

Session: DEB their Utility. Innovation in Drug Coated Balloons

Session: DEB their Utility. Innovation in Drug Coated Balloons Session: DEB their Utility 2 nd MARCH 2014 Innovation in Drug Coated Balloons Dr. Upendra Kaul Fortis Escorts Heart Institute New Delhi Disclosure I, Upendra Kaul, do not have a financial interest/arrangement

More information

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors

More information

Emerging Cardiac Technologies. Thomas D. Conley, MD FACC FSCAI BHHI Primary Care Symposium February 27, 2015

Emerging Cardiac Technologies. Thomas D. Conley, MD FACC FSCAI BHHI Primary Care Symposium February 27, 2015 Emerging Cardiac Technologies Thomas D. Conley, MD FACC FSCAI BHHI Primary Care Symposium February 27, 2015 None Financial Disclosures Examples of Emerging Technologies Therapeutic Bioabsorbable Stents

More information

DES in Diabetic Patients

DES in Diabetic Patients DES in Diabetic Patients Charles Chan, M.D., FACC Gleneagles Hospital Singapore TCT ASIA PACIFIC 2007 Why do diabetics have worse outcome after PCI? More extensive atherosclerosis and diffuse disease Increase

More information

Aortic Stenosis. TAVR available devices Ioannis Iakovou, MD, PhD

Aortic Stenosis. TAVR available devices Ioannis Iakovou, MD, PhD Aortic Stenosis. TAVR available devices Ioannis Iakovou, MD, PhD Interventional Cardiology Onassis Cardiac Surgery Center Athens, Greece TAVI in 2018: Landscape TAVI is a Breakthrough Technology Dramatic

More information

Bioresorbable stents for all or for few? Franz-Josef Neumann

Bioresorbable stents for all or for few? Franz-Josef Neumann Bioresorbable stents for all or for few? Franz-Josef Neumann Personal: None Institutional: Conflict of Interest Speaker honoraria, consultancy fees and research grants from Lilly, Daiichi Sankyo, Sanofi-Aventis,

More information

TAVI in Rabin Medical Center -

TAVI in Rabin Medical Center - Long-Term Outcomes of 560 Consecutive Patients treated with TAVI and Propensity Score Matched- Analysis of Early Versus New Generation Valves Amos Levi, MD, Uri Landes, MD, Abid R Assali, MD, Katia Orvin,

More information

Patrick W. Serruys MD. PhD. 1 Bernard Chevalier MD. 2 Yoshinobu Onuma MD. PhD. 3 on behalf of ABSORB II investigators

Patrick W. Serruys MD. PhD. 1 Bernard Chevalier MD. 2 Yoshinobu Onuma MD. PhD. 3 on behalf of ABSORB II investigators TCT 216, Washington convention center October 3 th 216, 8:3 am- Room 159 Level 1 Late breaking clinical trial and First report investigations Press Conf.1 ABSORB II: Three-year Clinical Outcomes from a

More information

Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques

Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques Pablo Codner, Abid Assali, Hanna Vaknin-Assa, Katia Orvin, Ram Sharony, Leor Perl, Gabriel Greenberg, Marina Kupershmidt,

More information

Euro Heart Survey New Programme Sentinel Registry Transcatheter Valve Treatment (TCVT) Carlo Di Mario, London, UK President EAPCI

Euro Heart Survey New Programme Sentinel Registry Transcatheter Valve Treatment (TCVT) Carlo Di Mario, London, UK President EAPCI Euro Heart Survey New Programme 2009-2012 Sentinel Registry Transcatheter Valve Treatment (TCVT) Carlo Di Mario, London, UK President EAPCI Alan Cribier, Rouen, France Andreas Gruentzig Award 2010 Cardiogenic

More information

Correlation of Abnormal Liver Function Tests in Patients with Severe Heart Failure to Outcomes.

Correlation of Abnormal Liver Function Tests in Patients with Severe Heart Failure to Outcomes. S7 - Prognosis and Outcome in Heart Failure Correlation of Abnormal Liver Function Tests in Patients with Severe Heart Failure to Outcomes. Avital Porter 1, Yatya Orvin 1, Benjamin Medalion 2,Eyal Porath

More information

Polymer-Free Stent CX - ISAR

Polymer-Free Stent CX - ISAR Polymer-Free Stent CX - ISAR Moo Hyun Kim, MD, FACC on behalf of Dr. Florian Krackhardt, Germany CX ISAR Stent : Features Intracoronary Stenting and Angiographic Results Strut Thickness of only 50/60 μm

More information

Surgeon Involvement in Transcatheter Valve Therapy

Surgeon Involvement in Transcatheter Valve Therapy Surgeon Involvement in Transcatheter Valve Therapy Prof. Hendrik Treede Mid-German Heartcenter University Hospital Halle (Saale) Once upon a time. classic interventional cardiology classic cardiac surgery

More information

Aortic Stenosis. TAVR available devices Ioannis Iakovou, MD, PhD

Aortic Stenosis. TAVR available devices Ioannis Iakovou, MD, PhD Aortic Stenosis. TAVR available devices Ioannis Iakovou, MD, PhD Interventional Cardiology Onassis Cardiac Surgery Center Athens, Greece Ομάδες εργασίας, Θεσσαλονίκη 2018 TAVI in 2018: Landscape TAVI is

More information

Side branch occlusion in 500 ABSORB BVS

Side branch occlusion in 500 ABSORB BVS Side branch occlusion in 500 ABSORB BVS Clinical implications and Solutions Robert-Jan van Geuns, MD, PhD Associate Professor,Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands On behalf

More information

Coronary Stent Choice in Patients With Diabetes Mellitus

Coronary Stent Choice in Patients With Diabetes Mellitus Rome Cardiology Forum 2014 Coronary Stent Choice in Patients With Diabetes Mellitus Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University

More information

The jailed side branch and OCT guided cross over. Accidental abluminal rewiring, OCT check or optimal technique?

The jailed side branch and OCT guided cross over. Accidental abluminal rewiring, OCT check or optimal technique? Friday October 18th EBC 2013 FINAL PROGRAMME Morning 09:00-09:30 EBC board meeting 09:30-11:30 Abbott meeting with EBC Board 10:30-12:30 St Jude Medical pre-meeting 12:00 13:00 - WELCOME LUNCH PARALLEL

More information

The 2 nd Royal Brompton & Harefield Christmas Postgraduate Course

The 2 nd Royal Brompton & Harefield Christmas Postgraduate Course The 2 nd Royal Brompton & Harefield Christmas Postgraduate Course The Royal Society of Medicine, 1 Wimpole St, Marylebone, London December 17 th 18 th, 2018 Course Directors Prof. Thomas F. Lüscher, FRCP,

More information

Long Term Outcomes of MGuard Stent Deployment in Saphenous Vein Grafts and Native Coronary Arteries: A Single Center Experience

Long Term Outcomes of MGuard Stent Deployment in Saphenous Vein Grafts and Native Coronary Arteries: A Single Center Experience Original Articles IMAJ VOL 19 march 2017 Long Term Outcomes of MGuard Stent Deployment in Saphenous Vein Grafts and Native Coronary Arteries: A Single Center Experience Hana Vaknin-Assa MD, Abid Assali

More information

EAPCI: Biodegradable Scaffolds-Writers 2016

EAPCI: Biodegradable Scaffolds-Writers 2016 Baumbach Andreas Byrne Robert - Medicines Company : Drugs (2015) - Abbott Vascular : Stents (2015) - Abbott Vascular : Stent (2015) - Boston Scientific : Medical devices (2015) - Biotronik : Medical devices

More information

Device and Clinical Program Highlights: SINOMED BuMA Stent

Device and Clinical Program Highlights: SINOMED BuMA Stent Device and Clinical Program Highlights: SINOMED BuMA Stent Runlin Gao, MD, FACC, FESC, FSCAI Fuwai Hospital, National Center for Cardiovascular Diseases, China CAMS, PUMC BuMA Supreme Platform and Pre-Clinical

More information

Stephen G. Ellis, M.D. Professor of Medicine Director Invasive Services Co-Director Cardiac Gene Bank

Stephen G. Ellis, M.D. Professor of Medicine Director Invasive Services Co-Director Cardiac Gene Bank From ABSORB Cohort A to ABSORB III and IV Randomized Trials Stephen G. Ellis, M.D. Professor of Medicine Director Invasive Services Co-Director Cardiac Gene Bank Disclosures Consultant, Abbott Vascular

More information

BIOFLOW V Comparison of UltraThin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus- Eluting Durable Polymer Stents

BIOFLOW V Comparison of UltraThin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus- Eluting Durable Polymer Stents Comparison of UltraThin Sirolimus-Eluting Bioresorbable Polymer with Thin Everolimus- Eluting Durable Polymer Stents David E Kandzari, MD; Laura Mauri, MD, MSc; Jacques Koolen, MD, PhD; Joseph M Massaro,

More information

Provisional T- sten/ng Future Outlook: Ra/onale of Plaque Incision + DCB

Provisional T- sten/ng Future Outlook: Ra/onale of Plaque Incision + DCB Provisional T- sten/ng Future Outlook: Ra/onale of Plaque Incision + DCB Dr. Azeem La/b EMO- GVM Centro Cuore Columbus and San Raffaele Scien/fic Ins/tute, Milan, Italy PCI in Coronary Bifurca/ons Up to

More information

Bioabsorbable Scaffolds: The Next Holy Grail?

Bioabsorbable Scaffolds: The Next Holy Grail? Bioabsorbable Scaffolds: The Next Holy Grail? New Cardiovascular Horizons New Orleans, LA June 06, 2013 Lewis B. Schwartz, M.D., F.A.C.S. Vascular Surgery and Endovascular Therapy University of Chicago

More information

The BIO revolution: bioadsorbable stents. Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino

The BIO revolution: bioadsorbable stents. Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino The BIO revolution: bioadsorbable stents Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino BVS stent (Abbot Vascular) Strut Material: Poly-L-Lactic acid Coating Material: Poly-D,L-lactide

More information

DRUG ELUTING STENTS. Cypher Versus Taxus: Are There Differences? Introduction. Methods SIGMUND SILBER, M.D., F.E.S.C., F.A.C.C.

DRUG ELUTING STENTS. Cypher Versus Taxus: Are There Differences? Introduction. Methods SIGMUND SILBER, M.D., F.E.S.C., F.A.C.C. DRUG ELUTING STENTS Cypher Versus Taxus: Are There Differences? SIGMUND SILBER, M.D., F.E.S.C., F.A.C.C. From the Cardiology Practice and Hospital, Munich, Germany Today, drug-eluting stents (DES) are

More information

Drug eluting balloons in CAD

Drug eluting balloons in CAD Drug eluting balloons in CAD Ioannis Iakovou, MD, PhD Interventional Cardiology 1 st Cath Lab Onassis Cardiac Surgery Center Drug-Eluting Balloons (DEB) Technology and Applications 1. Special Features

More information

Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G.

Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G. Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G. Ellis MD Dean J. Kereiakes MD and Gregg W. Stone MD for the ABSORB

More information

The role of bioabsorbable stents in the superficial femoral artery What is going on? Frank Vermassen Ghent University Hospital Belgium

The role of bioabsorbable stents in the superficial femoral artery What is going on? Frank Vermassen Ghent University Hospital Belgium The role of bioabsorbable stents in the superficial femoral artery What is going on? Frank Vermassen Ghent University Hospital Belgium Disclosures Speaker name: Frank Vermassen I have the following potential

More information

THE CURRENT SITUATION AND FUTURE OF THE PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROM IN RUSSIAN FEDERATION

THE CURRENT SITUATION AND FUTURE OF THE PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROM IN RUSSIAN FEDERATION : 616.127-005.8 -..,.. -...,, ( ), 2011, 581 182. 195 592 ( ) 385 590 -. 4,3 % 8,8 % ( ). 2011 62 329,, 24 931 (40 %) -. : - - ; ; 70 % ST ( ST); ST - 24. : ST,. THE CURRENT SITUATION AND FUTURE OF THE

More information

Il Cuore in Fortezza Savona, 9 Aprile 2015

Il Cuore in Fortezza Savona, 9 Aprile 2015 Il Cuore in Fortezza Savona, 9 Aprile 2015 Alaide Chieffo UO Emodinamica Ospedale San Raffaele, Milano Improvements for treatments of ST elevation myocardial infarction DES and New DES Functional revascularization

More information

Mitral Programme Update

Mitral Programme Update Direct Flow Medical Innovations in the Aortic and Mitral Programmes Mitral Programme Update Azeem Latib MD EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy Potential conflicts

More information

2-year outcome of the 3-arm BIO-RESORT randomized trial in all-comer patients treated with contemporary DES

2-year outcome of the 3-arm BIO-RESORT randomized trial in all-comer patients treated with contemporary DES 2-year outcome of the 3-arm BIO-RESORT randomized trial in all-comer patients treated with contemporary DES Marlies M. Kok, MD Thoraxcentrum Twente, MST, Enschede, the Netherlands On behalf of the BIO-RESORT

More information

TRIAL UPDATE 1. ISAR TRIPLE SECURITY Trial. Dr Deven Patel Royal Free Hospital

TRIAL UPDATE 1. ISAR TRIPLE SECURITY Trial. Dr Deven Patel Royal Free Hospital TRIAL UPDATE 1 ISAR TRIPLE SECURITY Trial Dr Deven Patel Royal Free Hospital NO CONFLICT OF INTEREST TO DECLARE ISAR TRIPLE Comparison of 6 weeks vs 6 months Triple Therapy in patients on oral anticoagulation

More information

Professional International Study Management

Professional International Study Management Professional International Study Management Services Phase I Study Consulting Phase II-IV IV Study Conduct for Drugs and Devices Protocol Design and Development Study Feasibilities Site Identification,

More information

ACVS INDIA 2017 PROGRAMME, HALL -A 18 th August 2017, HICC, HYDERABAD.

ACVS INDIA 2017 PROGRAMME, HALL -A 18 th August 2017, HICC, HYDERABAD. FA CTS FO UND ATI ON ACVS INDIA 2017 PROGRAMME, HALL -A 18 th August 2017, HICC, HYDERABAD. 08:00-08:30 Introduction & Welcome - ACVS Musical Extravaganza 08:30-09:30 Live Case I & II 09:30-9:40 What to

More information

Ενδοςτεφανιαίεσ προκζςεισ (stents):παρόν και μζλλον. Σ Χατηθμιλτιάδθσ Αναπλθρωτισ Κακθγθτισ Πανεπιςτθμιακό Νοςοκομείο ΑΧΕΠΑ

Ενδοςτεφανιαίεσ προκζςεισ (stents):παρόν και μζλλον. Σ Χατηθμιλτιάδθσ Αναπλθρωτισ Κακθγθτισ Πανεπιςτθμιακό Νοςοκομείο ΑΧΕΠΑ Ενδοςτεφανιαίεσ προκζςεισ (stents):παρόν και μζλλον Σ Χατηθμιλτιάδθσ Αναπλθρωτισ Κακθγθτισ Πανεπιςτθμιακό Νοςοκομείο ΑΧΕΠΑ DES Penetration -(2011) Source: Millenium Research Group Cordis has stopped manufacturing

More information

Moins de 6 mois d antiagrégants après DES?

Moins de 6 mois d antiagrégants après DES? Moins de 6 mois d antiagrégants après DES? High Tech - Marseille 25 au 27 janvier 2011 Marie-Claude MORICE, MD, FESC, FACC Massy, France Pas de conflit d interet Was optimal duration of DAPT already established

More information

Βιοαποδομήσιμα Στεφανιαία Ικριώματα με βάση το μαγνήσιο. Magnesium Bioresorbable Coronary Scaffolds

Βιοαποδομήσιμα Στεφανιαία Ικριώματα με βάση το μαγνήσιο. Magnesium Bioresorbable Coronary Scaffolds Βιοαποδομήσιμα Στεφανιαία Ικριώματα με βάση το μαγνήσιο. Magnesium Bioresorbable Coronary Scaffolds Βάιος Π. Τζίφος Δ/ντής Τμήματος Επεμβατικής Καρδιολογίας Ερρίκος Ντυνάν HC Δεν υπάρχει σύγκρουση συμφερόντων

More information

S26 Hemodynamic Effect of Transcatheter Aortic Valve Replacement in Low Gradient Severe Aortic Stenosis

S26 Hemodynamic Effect of Transcatheter Aortic Valve Replacement in Low Gradient Severe Aortic Stenosis S26 Hemodynamic Effect of Transcatheter Aortic Valve Replacement in Low Gradient Severe Aortic Stenosis Birati, Edo Y. ; Topilsky, Yan; Abramovich, Yigal; Steinvil, Arie; Finkelstein, Ariel; Biner, Simon

More information

Additional Contributor: Glenn Levine (USA).

Additional Contributor: Glenn Levine (USA). 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the Management

More information

CARDIOLOGY NEWSLETTER

CARDIOLOGY NEWSLETTER CARDIOLOGY NEWSLETTER Congress and Events PCR London Valves Webcast: The ACURATE neo TAVI System, symplifying TAVI procedures Short DAPT Trial with SYNERGY BP Stent: Superior outcomes in Elderly Patients

More information

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL Pathology of percutaneous interventions (PCI) in coronary arteries Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL Percutaneous Coronary Intervention (PCI) Definition: transcatheter opening of

More information

REFCTRI/2010/ CTRI Website URL -

REFCTRI/2010/ CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Mon, 23 Apr 2018 20:30:46 GMT) CTRI Number CTRI/2010/091/000460 [Registered on: 15/10/2010] - Last Modified On 17/04/2012 Post Graduate Thesis Type of Trial

More information

Early Experience of Transcatheter Mitral Valve Replacement Results from the Intrepid Global Pilot Study

Early Experience of Transcatheter Mitral Valve Replacement Results from the Intrepid Global Pilot Study Early Experience of Transcatheter Mitral Valve Replacement Results from the Paul Sorajja, MD for the Investigators Presenter Disclosure Information Within the past 12 months, I or my spouse/partner have

More information

Sixth Bulgarian Bifurcation and Complex Coronary Interventions Course January 2017 Sofia, Tokuda Hospital PRELIMINARY PROGRAM

Sixth Bulgarian Bifurcation and Complex Coronary Interventions Course January 2017 Sofia, Tokuda Hospital PRELIMINARY PROGRAM European Bifurcation Club Bulgarian Society of Interventional Cardiology Bulgarian Society of Cardiology in Bulgaria Sixth Bulgarian Bifurcation and Complex Coronary Interventions Course 20 22 January

More information

Bernard Chevalier Institut Jacques Cartier, Massy, France. Patrick W. Serruys Imperial College, London, UK Erasmus University MC, Netherlands

Bernard Chevalier Institut Jacques Cartier, Massy, France. Patrick W. Serruys Imperial College, London, UK Erasmus University MC, Netherlands The 4-year Clinical Outcomes of the ABSORB II Trial: First Randomized Comparison between the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold and the XIENCE Everolimus Eluting Stent Bernard Chevalier

More information

Stent Thrombosis: Patient, Procedural, and Stent Factors. Eugene Mc Fadden Cork, Ireland

Stent Thrombosis: Patient, Procedural, and Stent Factors. Eugene Mc Fadden Cork, Ireland Stent Thrombosis: Patient, Procedural, and Stent Factors Eugene Mc Fadden Cork, Ireland Definitions Early 1 yr TAXUS >6months CYPHER Incidence and Timing BMS Registry data

More information

New joy of cardiac disease

New joy of cardiac disease New joy of cardiac disease Coronary artery disease CT coronary angiography The bioabsorbable stent Valvular heart disease Percutaneous aortic valve replacement Mitral clip for mitral incompetence Arrhythmias

More information

SCAAR: Lower late and very late stent thrombosis rates with new generation drug eluting stents compared to bare metal stents

SCAAR: Lower late and very late stent thrombosis rates with new generation drug eluting stents compared to bare metal stents SCAAR: Lower late and very late stent thrombosis rates with new generation drug eluting stents compared to bare metal stents Christoph Varenhorst, Giovanna Sarno, Göran Olivecrona, Per Tornvall, Johan

More information

TCT mdbuyline.com Clinical Trial Results Summary

TCT mdbuyline.com Clinical Trial Results Summary TCT 2012 Clinical Trial Results Summary FAME2 Trial: FFR (fractional flow reserve) guided PCI in all target lesions Patients with significant ischemia, randomized 1:1 Control arm: not hemodynamically significant

More information

Bioresorbable Scaffolds Moving Forward or Backwards?

Bioresorbable Scaffolds Moving Forward or Backwards? Bioresorbable Scaffolds Moving Forward or Backwards? George D. Dangas, MD, FACC, MSCAI Professor of Cardiology & Vascular Surgery Icahn School of Medicine at Mount Sinai New York, NY Disclosure Statement

More information

4:30 p.m. Jack Vogel Memorial Lecture Evolution and Revolution in the Treatment of Valvular Heart Disease Dr. Mack

4:30 p.m. Jack Vogel Memorial Lecture Evolution and Revolution in the Treatment of Valvular Heart Disease Dr. Mack AGENDA Friday, January 12 4:30 p.m. Registration at Westin Snowmass Conference Center 6:30 p.m. Saturday, January 13 3:30 p.m. Registration and Refreshment Break SESSION I Moderator: 4:00 p.m. Welcome

More information

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes 8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference 2017 Dubai: 19-21 October 2017 Acute Coronary Syndromes Antonio Colombo Centro Cuore Columbus and S. Raffaele Scientific

More information

Magmaris Stent (Biotronik) A Pichard, Ron Waksman. Medstar Washington Hospital Center Washington, DC

Magmaris Stent (Biotronik) A Pichard, Ron Waksman. Medstar Washington Hospital Center Washington, DC Magmaris Stent (Biotronik) A Pichard, Ron Waksman. Medstar Washington Hospital Center Washington, DC Conflict of Interest None for this presentation Downside of Metallic Stents 1. Restenosis No longer

More information

7 th Conference of Transcatheter Heart Valve Therapies

7 th Conference of Transcatheter Heart Valve Therapies 7 th Conference of Transcatheter Heart Valve Therapies May 18-19, 2018, Athens Hilton Athens, Greece Course Directors Stratis Pattakos MD Konstantinos Spargias MD Panos Vardas MD Co-Directors Nick Bouboulis

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

National Intervention Council

National Intervention Council National Intervention Council Cardiological Society of India Registry Performa for Coronary, Non- Coronary & Peripheral Interventions Period January 1st 2016 to December 31 st 2016 Dr. (Prof.) N.N. Khanna

More information

What Stent to Use? JASVINDAR SINGH MD, FACC

What Stent to Use? JASVINDAR SINGH MD, FACC What Stent to Use? JASVINDAR SINGH MD, FACC ASSOCIATE PROFESSOR OF MEDICINE WASHINGTON UNIVERSITY IN ST. LOUIS DIRECTOR, CARDIAC CATHETERIZATION LAB BARNES-JEWISH HOSPITAL What Stent to Use? Jasvindar

More information

ADVANCED TAVI IMAGING

ADVANCED TAVI IMAGING Program Directors Antonio Colombo, MD, Milan, Italy Markus Kasel, MD, Munich, Germany Susheel K. Kodali, MD, New York, NY Martin B. Leon, MD, New York, NY ADVANCED TAVI IMAGING 7 Program Wednesday 03.12.2014

More information